Dr. Sebastian Jud



Organisation


Frauenklinik


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 4 Go to next page Go to last page

Wunderle, M., Pretscher, J., Brucker, S.Y., Volz, B., Hartmann, A., Fiessler, C.,... Rauh, C. (2019). Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer. Breast Cancer Research and Treatment, 174(2), 453-461. https://dx.doi.org/10.1007/s10549-018-05115-6
Lux, M.P., Emons, J., Bani, M., Wunderle, M., Sell, C., Preuss, C.,... Gaß, P. (2019). Diagnostic Accuracy of Breast Medical Tactile Examiners (MTEs): A Prospective Pilot Study. Breast Care, 14(1), 41-47. https://dx.doi.org/10.1159/000495883
Fasching, P., Gaß, P., Häberle, L., Volz, B., Hein, A., Hack, C.,... Erber, R. (2019). Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer. Breast Cancer Research and Treatment. https://dx.doi.org/10.1007/s10549-019-05198-9
Häberle, L., Erber, R., Gaß, P., Hein, A., Jud, S., Langemann, H.,... Fasching, P. (2018). A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients. In ANNALS OF ONCOLOGY. Munich, DE: OXFORD: OXFORD UNIV PRESS.
Wunderle, M., Gaß, P., Häberle, L., Flesch, V.M., Rauh, C., Bani, M.,... Hein, A. (2018). BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients. Breast Cancer Research and Treatment, 171(1), 85-94. https://dx.doi.org/10.1007/s10549-018-4797-8
Emons, J., Wunderle, M., Hartmann, A., Radicke, M., Rauh, C., Uder, M.,... Jud, S. (2018). Initial clinical results with a fusion prototype for mammography and three-dimensional ultrasound with a standard mammography system and a standard ultrasound probe. Acta Radiologica, 59(12), 1406-1413. https://dx.doi.org/10.1177/0284185118762249
Wunderle, M., Olmes, G., Nabieva, N., Häberle, L., Jud, S., Hein, A.,... Fasching, P.A. (2018). Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data. Geburtshilfe und Frauenheilkunde, 78(5), 481-492. https://dx.doi.org/10.1055/a-0603-4350
Würfel, F., Erber, R., Hübner, H., Hein, A., Lux, M.P., Jud, S.,... Rübner, M. (2018). TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes. Breast Care, 13(1), 8-14.
Erber, R., Hartmann, A., Beckmann, M., Mackensen, A., Kremer, A., Reimann, H.,... Fasching, P.A. (2018). TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes. Pathologe, 39(Suppl 2), 236-240. https://dx.doi.org/10.1007/s00292-018-0526-7
Gaß, P., Untch, M., Mueller, V., Moebus, V., Thomssen, C., Häberle, L.,... Nabieva, N. (2018). Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians. Geburtshilfe und Frauenheilkunde, 78(7), 707-714. https://dx.doi.org/10.1055/a-0642-9462

Last updated on 2017-12-10 at 02:01